Promoter control over foreign antigen expression in a murine cytomegalovirus vaccine vector

Vaccine

Volumn 29, Issue 1, 2010, Pages 141-151

  Cunningham, Paula T ^a,b   Lloyd, Megan L ^a,b   Harvey, Nicole L ^a,b   Williams, Elizabeth ^a,b   Hardy, Christopher M ^b   Redwood, Alec J ^a,b   Lawson, Malcolm A ^a,b   Shellam, Geoffrey R ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b CSIRO   (Australia)

Author keywords

Immunocontraception; Promoter control; Species specificity

Indexed keywords

COMPLEMENTARY DNA; CONTRACEPTIVE AGENT; GLYCOPROTEIN E1; IMMEDIATE EARLY PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; MOUSE ZONA PELLUCIDA 3 PROTEIN; MURINE CYTOMEGALOVIRUS VECTOR; TETRACYCLINE; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BAGG ALBINO MOUSE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; EMBRYO; FEMALE; FEMALE STERILIZATION; GENE CONTROL; GENE EXPRESSION; IMMEDIATE EARLY GENE; IMMUNE RESPONSE; IMMUNOCONTRACEPTION; INFERTILITY; MALE; MOUSE; MURINE CYTOMEGALOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS ATTENUATION; VIRUS RECOMBINANT; VIRUS REPLICATION; ZONA PELLUCIDA;

ANIMALS; ANTIGENS; EGG PROTEINS; FEMALE; GENETIC VECTORS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUROMEGALOVIRUS; OVALBUMIN; PROMOTER REGIONS, GENETIC; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; VACCINES, CONTRACEPTIVE;

EID: 78649702864     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.03.012     Document Type: Article

References (46)

1. Lagenaur L.A., Manning W.C., Vieira J., Martens C.L., Mocarski E.S. Structure and function of the murine cytomegalovirus sgg1 gene: a determinant of viral growth in salivary gland acinar cells. J Virol 1994, 68(12):7717-7727.
2. Manning W.C., Mocarski E.S. Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology 1988, 167(2):477-484.
3. Jurak I., Brune W. Induction of apoptosis limits cytomegalovirus cross-species infection. EMBO J 2006, 25(11):2634-2642.
4. Shellam G.R., Redwood A.J., Smith L.M., Gorman S. Murine cytomegaloviruses and other herpesviruses. The mouse in biomedical research 2007, vol. 2:1-48. Academic Press, Amsterdam.
5. Kurz S., Steffens H.P., Mayer A., Harris J.R., Reddehase M.J. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol 1997, 71(4):2980-2987.
6. Balthesen M., Messerle M., Reddehase M.J. Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 1993, 67(9):5360-5366.
7. Fleming P., Davis-Poynter N., Degli-Esposti M., Densley E., Papadimitriou J., Shellam G., et al. The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity. J Virol 1999, 73(8):6800-6809.
8. Shellam G.R. The potential of murine cytomegalovirus as a viral vector for immunocontraception. Reprod Fertil Dev 1994, 6(3):401-409.
9. Singleton G.R., Brown P.R., Pech R.P., Jacob J., Mutze G.J., Krebs C.J. One hundred years of eruptions of house mice in Australia-a natural biological curio. Biol J Linn Soc 2005, 84(3):617-627.
10. Caughley J., Monamy V., Heiden K. Impact of the 1993 mouse plague-occasional paper no. 7 1994, Grains Research & Development Corporation, Canberra.
11. Lloyd M.L., Shellam G.R., Papadimitriou J.M., Lawson M.A. Immunocontraception is induced in BALB/c mice inoculated with murine cytomegalovirus expressing mouse zona pellucida 3. Biol Reprod 2003, 68(6):2024-2032.
12. Redwood A.J., Harvey N.L., Lloyd M., Lawson M.A., Hardy C.M., Shellam G.R. Viral vectored immunocontraception: screening of multiple fertility antigens using murine cytomegalovirus as a vaccine vector. Vaccine 2007, 25(4):698-708.
13. Redwood A.J., Messerle M., Harvey N.L., Hardy C.M., Koszinowski U.H., Lawson M.A., et al. Use of a Murine Cytomegalovirus, K181-derived, bacterial artificial chromosome as a vaccine vector for immunocontraception. J Virol 2005, 79(5):2998-3008.
14. Lloyd M.L., Nikolovski S., Lawson M.A., Shellam G.R. Innate antiviral resistance influences the efficacy of a recombinant murine cytomegalovirus immunocontraceptive vaccine. Vaccine 2007, 25(4):679-690.
15. Scalzo A.A., Manzur M., Forbes C.A., Brown M.G., Shellam G.R. NK gene complex haplotype variability and host resistance alleles to murine cytomegalovirus in wild mouse populations. Immunol Cell Biol 2005, 83(2):144-149.
16. Cardin R.D., Abenes G.B., Stoddart C.A., Mocarski E.S. Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice. Virology 1995, 209(1):236-241.
17. Smith L.M., Lloyd M.L., Harvey N.L., Redwood A.J., Lawson M.A., Shellam G.R. Species-specificity of a murine immunocontraceptive utilising murine cytomegalovirus as a gene delivery vector. Vaccine 2005, 23(23):2959-2969.
18. Foecking M.K., Hofstetter H. Powerful and versatile enhancer-promoter unit for mammalian expression vectors. Gene 1986, 45(1):101-105.
19. Lawson C.M., Grundy J.E., Shellam G.R. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. J Gen Virol 1988, 69(Pt 8):1987-1998.
20. Xu J., Dallas P.B., Lyons P.A., Shellam G.R., Scalzo A.A. Identification of the glycoprotein H gene of murine cytomegalovirus. J Gen Virol 1992, 73(Pt 7):1849-1854.
21. Manning W.C., Stoddart C.A., Lagenaur L.A., Abenes G.B., Mocarski E.S. Cytomegalovirus determinant of replication in salivary glands. J Virol 1992, 66(6):3794-3802.
22. Maniatis T., Fritsch E.F., Sambrook J. Molecular cloning: a laboratory manual 1982, Cold Spring Harbor Laboratory, New York.
23. Kurts C., Heath W.R., Carbone F.R., Allison J., Miller J.F., Kosaka H. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996, 184(3):923-930.
24. Gorman S., Harvey N.L., Moro D., Lloyd M.L., Voigt V., Smith L.M., et al. Mixed infection with multiple strains of murine cytomegalovirus occurs following simultaneous or sequential infection of immunocompetent mice. J Gen Virol 2006, 87(Pt 5):1123-1132.
25. Oehen S., Brduscha-Riem K. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J Immunol 1998, 161(10):5338-5346.
26. East I.J., Gulyas B.J., Dean J. Monoclonal antibodies to the murine zona pellucida protein with sperm receptor activity: effects on fertilization and early development. Dev Biol 1985, 109(2):268-273.
27. Sipo I., Hurtado Picó A., Wang X., Eberle J., Petersen I., Weger S., et al. An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy. J Mol Med 2006, 84(3):215-225.
28. Boyle J.S., Koniaras C., Lew A.M. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int Immunol 1997, 9(12):1897-1906.
29. Krmpotic A., Bubic I., Polic B., Lucin P., Jonjic S. Pathogenesis of murine cytomegalovirus infection. Microbes Infect 2003, 5(13):1263-1277.
30. Hengel H., Reusch U., Gutermann A., Ziegler H., Jonjic S., Lucin P., et al. Cytomegaloviral control of MHC class I function in the mouse. Immunol Rev 1999, 168:167-176.
31. Andrews D.M., Andoniou C.E., Granucci F., Ricciardi-Castagnoli P., Degli-Esposti M.A. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol 2001, 2(11):1077-1084.
32. Loewendorf A., Krüger C., Wagner M., Just U., Messerle M. Identification of a mouse cytomegalovirus gene targeting CD86 expression on antigen presenting cells. Proceedings of the 28th international herpesvirus workshop 2003, 11.06.
33. Wang X., Messerle M., Sapinoro R., et al. Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genes. J Virol 2003, 77(13):7182-7192.
34. Keil G.M., Ebeling-Keil A., Koszinowski U.H. Immediate-early genes of murine cytomegalovirus: location, transcripts, and translation products. J Virol 1987, 61(2):526-533.
35. Bruggeman C.A., Meijer H., Dormans P.H., Debie W.M., Grauls G.E., van Boven C.P. Isolation of a cytomegalovirus-like agent from wild rats. Arch Virol 1982, 73(3-4):231-241.
36. Smith C.B., Wei L.S., Griffiths M. Mouse cytomegalovirus is infectious for rats and alters lymphocyte subsets and spleen cell proliferation. Arch Virol 1986, 90(3-4):313-323.
37. Garcia-Ramirez J.J., Ruchti F., Huang H., Simmen K., Angulo A., Ghazal P. Dominance of virus over host factors in cross-species activation of human cytomegalovirus early gene expression. J Virol 2001, 75(1):26-35.
38. Kim K.S., Carp R.I. Growth of murine cytomegalovirus in various cell lines. J Virol 1971, 7(6):720-725.
39. LaFemina R.L., Hayward G.S. Differences in cell-type-specific blocks to immediate early gene expression and DNA replication of human, simian and murine cytomegalovirus. J Gen Virol 1988, 69(Pt 2):355-374.
40. Tang Q., Maul G.G. Mouse cytomegalovirus crosses the species barrier with help from a few human cytomegalovirus proteins. J Virol 2006, 80(15):7510-7521.
41. Walker D., Hudson J. Analysis of immediate-early and early proteins of murine cytomegalovirus in permissive and nonpermissive cells. Arch Virol 1987, 92(1-2):103-119.
42. Schultze N., Burki Y., Lang Y., Certa U., Bluethmann H. Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nat Biotechnol 1996, 14(4):499-503.
43. Strathdee C.A., McLeod M.R., Hall J.R. Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector. Gene 1999, 229(1-2):21-29.
44. Freundlieb S., Schirra-Muller C., Bujard H. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med 1999, 1(1):4-12.
45. Salucci V., Scarito A., Aurisicchio L., et al. Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2(s)-M2 tetracycline transactivator and repressor system. Gene Ther 2002, 9(21):1415-1421.
46. Urlinger S., Baron U., Thellmann M., Hasan M.T., Bujard H., Hillen W. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 2000, 97(14):7963-7968.